Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Biora Therapeutics, Inc. (BIORQ : OTC)

• Company Description    Biora Therapeutics Inc. is a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond. Biora Therapeutics Inc., formerly known as Progenity Inc., is based in SAN DIEGO. Number of Employees: 58

• Price / Volume Information    Yesterday's Closing Price: $0.31 Daily Weekly Monthly 20 Day Moving Average: 12,301 shares Shares Outstanding: 4.52 (millions) Market Capitalization: $1.40 (millions) Beta: 1.30 52 Week High: $0.76 52 Week Low: $0.08 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 126.28% 117.80% 12 Week 164.51% 122.48% Year To Date 67.57% 56.93%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 4330 LA JOLLA VILLAGE DRIVE SUITE 200 - SAN DIEGO,CA 92122 USA ph: 833-727-2841 fax: - ir@bioratherapeutics.com http://www.bioratherapeutics.com

• General Corporate Information    Officers Aditya P. Mohanty - Chief Executive Officer Eric d'Esparbes - Chief Financial Officer Jeffrey Alter - Director Jeffrey Ferrell - Director Jill Howe - Director Peer Information Biora Therapeutics, Inc. (CORR.) Biora Therapeutics, Inc. (RSPI) Biora Therapeutics, Inc. (CGXP) Biora Therapeutics, Inc. (BGEN) Biora Therapeutics, Inc. (GTBP) Biora Therapeutics, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 74319F404 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/24 Next Expected EPS Date: 08/11/25 Share - Related Items Shares Outstanding: 4.52 Most Recent Split Date: 10.00 (0.10:1) Beta: 1.30 Market Capitalization: $1.40 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 18.93% vs. Previous Quarter: -73.71% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -89.94% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - - Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©